FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028093661> ?p ?o ?g. }

• W2028093661 endingPage "267" @default.
• W2028093661 startingPage "255" @default.
• W2028093661 abstract "Journal of Autonomic PharmacologyVolume 1, Issue 3 p. 255-267 HISTORICAL PERSPECTIVE NORADRENERGIC NEURONE BLOCKING AGENTS A. L. A. BOURA, A. L. A. BOURA Department of Pharmacology, Monash University, Clayton, Victoria, Australia 3168Search for more papers by this authorA. F. GREEN, A. F. GREEN The Wellcome Research Laboratories, Langley Court, Beckenham, Kent, UK2Search for more papers by this author A. L. A. BOURA, A. L. A. BOURA Department of Pharmacology, Monash University, Clayton, Victoria, Australia 3168Search for more papers by this authorA. F. GREEN, A. F. GREEN The Wellcome Research Laboratories, Langley Court, Beckenham, Kent, UK2Search for more papers by this author First published: June 1981 https://doi.org/10.1111/j.1474-8673.1981.tb00454.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References ABBS, E. T. & PYCOCK, C. J. (1973). The effects of bretylium on the subcellular distribution of noradrenaline and on adrenergic nerve function in rat heart. Br. J. Pharmac., 49, 11–22. ABBS, E. T. & PYCOCK, C. J. (1974). The effect of bretylium on endogenous and newlysynthesised noradrenaline in the microsomal fraction of rat heart. Br. J. Pharmac., 50, 606–608. ABBS, E. T. & ROBERTSON, M. I. (1970). Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium. Br. J. Pharmac., 38, 776–791. ARMSTRONG, J. M. & BOURA, A. L. A. (1970). Relative susceptibility of peripheral sympathetic nerves to adrenergic neurone blockade by bethanidine. Brit. J. Pharmac., 40, 551P. ARMSTRONG, J. M. & BOURA, A. L. A. (1973). Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Br. J. Pharmac., 47, 850–852. ARMSTRONG, J. M. & GREEN, A. F. (1980). Evaluation of agents that release or modify release of adrenergic transmitter. In Handb. exp. Pharm. 54/1: Adrenergic activators and inhibitors. L. Szekeres Ed. pp. 135–221. Berlin , Heidelberg , New York : Springer-Verlag. BACQ, Z. M. (1936). Action des amines sur la membrane nictitante et modifications de cette action par la cocaine et l'énervation. Mem. Acad. roy. de. med. de Belgique. 25, 1–61. BAIN, W. A. (1960). Interference with the release of transmitter in response to nerve stimulation. In Ciba Foundation Symposium on Adrenergic Mechanisms. March 2831, 1960, London . J. R. Vane, G. E. W. Wolstenholme, M. O'Connor Eds. pp. 131–147. London : Churchill. BEIN, H. J. (1960). Some pharmacological properties of guanethidine. In Ciba Foundation Symposium on Adrenergic Mechanisms. March 2831, 1960, London . J. R. Vane, G. E. W. Wolstenholme, M. Eds. O'Connor pp. 162–172. London : Churchill. BOULLIN, D. J., COSTA, E. & BRODIE, B. B. (1966). Discharge of tritium-labelled guanethidine by sympathetic nerve stimulation as evidence that guanethidine is a false transmitter. Life Sci., 5, 803–808. BOURA, A. L. A. (1967). Drug induced changes in the sensitivity of peripheral adrenergically innervated tissues. Ph.D. Thesis. London University. BOURA, A. L. A., COPP, F. C., DUNCOMBE, W. G., GREEN A. F. & MCCOUBREY, A. (1960b). The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves. Br. J. Pharmac., 15, 265–270. BOURA, A. L. A., COKER, G. G., COPP, F. C., DUNCOMBE, W. G., ELPHICK, A. R., GREEN, A. F. & MCCOUBREY, A. (1960a). Powerful adrenergic neurone-blocking agents related to choline 2, 6-xylyl ether bromide. Nature, 185, 925–926. BOURA, A. L. A., COPP, F. C. & GREEN, A. F. (1959a). New Antiadrenergic Compounds. Nature, 184, B.A. 70–71. BOURA, A. L. A., COPP, F. C., GREEN, A. F., HODSON, H. R., RUFFELL, G. K., SIM, M. F., WALTON, E. & GRIVSKY, E. M. (1961a). Adrenergic neurone-blocking agents related to choline 2, 6-xylyl ether bromide (TM10), bretylium and guanethidine. Nature, 191, 1312–1313. BOURA, A. L. A., DUNCOMBE, W. G. & MCCOUBREY, A. (1961b). The distribution of some quaternary ammonium salts in the peripheral nervous system of cats in relation to the adrenergic blocking action of bretylium. Br. J. Pharmac., 17, 92–100. BOURA, A. L. A., DUNCOMBE, W. G., ROBSON, R. D. & MCCOUBREY, A. (1962). The distribution and excretion by cats of a new hypotensive drug, N-benzyl-N'N-dimethylguanidine. J. Pharm. Pharmac., 14, 722–726. BOURA, A. L. A. & GREEN, A. F. (1959). The actions of bretylium: adrenergic neurone blocking and other effects. Br. J. Pharmac., 14, 536–548. BOURA, A. L. A. & GREEN, A. F. (1962). Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathetic amines. Br. J. Pharmac. 19, 13–41. BOURA, A. L. A. & GREEN, A. F. (1963). Adrenergic neurone blockade and other acute effects caused by N-benzyl-N'N dimethylguanidine and its ortho chloro derivative. Br. J. Pharmac., 20, 36–55. BOURA, A. L. A. & GREEN, A. F. (1965). Adrenergic neurone blocking agents. Ann. Rev. Pharmacol., 5, 183–212. BOURA, A. L. A., GREEN, A. F., MCCOUBREY, A., LAURENCE, D. R., MOULTON, R. & ROSENHEIM, M. L. (1959b). Darenthin. Hypotensive agent of new type. Lancet, ii, 17–21. BOYD, H., CHANG, V. & RAND, M. J. (1961). The local anaesthetic activity of bretylium in relation to its action in blocking sympathetic responses. Arch. Intern. Pharmacodyn., 131, 10–23. BULBRING, E. & BURN, J. H. (1949). Liberation of noradrenaline from the suprarenal gland. Br. J. Pharmac., 4, 202–208. BURGEN, A. S. V. & IVERSEN, L. L. (1965). The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart. Br. J. Pharmac., 25, 34–49. BURN, J. H. (1963). The Autonomic Nervous System, Blackwell, Oxford . BURN, J. H. & RAND, M. J. (1959). Sympathetic postganglionic mechanism. Nature, 184, 163–165. BURN, J. H. & RAND, M. J. (1960). Sympathetic postganglionic cholinergic fibres. Br. J. Pharmac., 15, 56–66. BURNSTOCK, G. (1979). Morphological changes produced by drugs acting on the autonomic nervous system. Pharmac. Ther., 5, 49–53. BURNSTOCK, G., EVANS, B., GANNON, B. J., HEATH, J. W. & JAMES, V. (1971). A new method of destroying adrenergic nerves in adult animals using guanethidine. Br. J. Pharmac., 43, 295–301. CABRERA, R., TORRANCE, R. W. & VIVEROS, H. (1966). The action of acetylcholine and other drugs upon the terminal parts of the postganglionic sympathetic fibre. Br. J. Pharmac., 27, 51–63. CANNON, W. B. (1939). A law of denervation. Am. J. Med. Sci., 198, 737–750. CANNON, W. B. & ROSENBLUETH, A. (1949). The supersensitivity of denervated structures. A Law of Denervation. Macmillan, New York . CASS, R. & SPRIGGS, T. L. B. (1961). Tissue amine levels and sympathetic blockade after guanethidine and bretylium. Br. J. Pharmac., 17, 442–450. CHANG, C. C., COSTA, E. & BRODIE, B. B. (1964). Reserpine-induced release of drugs from sympathetic nerve endings. Life Sci., 3, 839–844. CHANG, C. C., COSTA, E. and BRODIE, B. B. (1965). Interaction of guanethidine with adrenergic neurones. J. Pharmac. exper. Therap., 147, 303–312. COPP, F. C. (1964). Adrenergic neurone blocking agents. In Advances in Drug Research, 1, 161–189. COPP, F. C., STANDEN, O. D., SCARNELL, J., RAWES, D. A., & BURROWS, R. B. (1958). A new series of anthelmintics. Nature, 181, 183. DAY, M. D. (1962). Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine. Br. J. Pharmac., 18, 421–439. DAY, M. D. & RAND, M. J. (1963). Evidence for a competitive antagonism of guanethidine by dexamphetamine. Br. J. Pharmac., 20, 17–28. DOLLERY, C. T., EMSLIE-SMITH, D. & MILNE, M. D. (1960). Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet, ii, 381–387. EVANS, B., IWAYAMA, T. & BURNSTOCK, G. (1973). Long-lasting supersensitivity of the rat vas deferens to norepinephrine after chronic guanethidine administration. J. Pharmac. exp. Ther., 185, 60–69. EXLEY, K. A. (1957). The blocking action of choline 2:6-xylyl ether bromide on adrenergic nerves. Br. J. Pharmac., 12, 297–305. EXLEY, K. A. (1960). The persistence of adrenergic nerve conduction after TM10 or bretylium in the cat. In Ciba Foundation Symposium on Adrenergic Mechanisms. March 2831, 1960, London . J. R. Vane, G. E. W. Wolstenholme, M. Eds. O'Connor pp. 158–161. London : Churchill. FERRY, C. B. (1966). Cholinergic link hypothesis in adrenergic neuroeffector transmission. Physiol. Rev., 46, 420–456. FINKLEMAN, B. (1930). On the nature of inhibition in the intestine. J. Physiol., 70, 145–157. GIACHETTI, A. & SHORE, P. A. (1967). Monoamine oxidase inhibition in the adrenergic neuron by bretylium, debrisoquin, and other adrenergic neuronal blocking agents. Biochem. Pharmac., 16, 237–238. GREEN, A. F. (1956). The ganglion-blocking actions of the diquaternary amino benzhydryl nitriles 356C54 and 139C55. In Hypotensive Drugs. Proc. Symp. on Hypotensive Drugs and the Control of Vascular Tone in Hypertension. The Wellcome Foundation, London . M. Harington Ed. pp 95–99. London & New York : Pergamon Press. GREEN, A. F. (1960). The effects of bretylium and allied agents on adrenergic neurones. In Ciba Foundation Symposium on Adrenergic Mechanisms. March 2831. 1960, London . J. R. Vane, G. E. W. Wolstenholme, M. O'Connor Eds. pp 148–157. London : Churchill. GREEN, A. F. (1962). Antihypertensive Drugs. In Advances in Pharmacology, 1, 161–225. New York : Academic Press Inc. GREEN, A. F. & BOURA, A. L. A. (1964). Depressants of peripheral sympathetic nerve function. In Evaluation of Drug Activities: Pharmacometrics. Vol. 1, 369–430. ed. D. R. Laurence & A. L. Bacharach London , Academic Press. GREEN, A. F. & HUGHES, R. (1966). Effects of adrenergic neurone blocking agents on voluntary muscle stimulated at different frequencies. Br. J. Pharmac., 27, 164–176. GREEN, A. F. & ROBSON, R. D. (1964). Comparison of the effects of bretylium, guanethidine and bethanidine on smooth muscle responses to different rates of sympathetic nerve stimulation. Br. J. Pharmac., 22, 349–355. GREEN, A. F. & ROBSON, R. D. (1965). Adrenergic neurone blocking agents: tolerance and hypersensitivity to adrenaline and noradrenaline. Br. J. Pharmac., 25, 497–506. HAEUSLER, G. (1971). Physiology and Pharmacology of Vascular Neuroeffector Systems. p. 139–140. ed. J. A. Bevan Basel : Karger. HAEUSLER, G., HAEFELY, W., & HUERLIMANN, A. (1969). On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn-Schmiedebergs. Arch. exp. Path. Pharmak. 265, 260–277. HAEUSLER, G., THOENEN, H., HAEFELY, W. & HUERLIMANN, A. (1968). Durch Acetylcholin hervorgerufene antidrome Aktivitat im kardialen Sympathicus und Noradrenalinfrisetzung unter Guanethidin. Helv. Physiol. Pharmacol. Acta, 26, CR352–354. HEY, P. (1952). On relationships between structure and nicotine-like stimulant activity in choline esters and ethers. Br. J. Pharmac., 7, 117–129. HEY, P. & WILLEY, G. L. (1953). Choline 2:6-xylyl ether bromide; an active quaternary local anaesthetic. J. Physiol. (Lond), 122, 75P–76P. HEY, P. & WILLEY, G. L. (1954). Choline 2:6-xylyl ether bromide; an active quaternary local anaesthetic. Br. J. Pharmac., 9, 471–475. HUKOVIC, S. (1960). The action of sympathetic blocking agents on isolated and innervated atria and vessels. Br. J. Pharmac., 15, 117–121. IVERSEN, L. L. (1971). Role of transmitter uptake mechanisms in synaptic neuro-transmission. Br. J. Pharmac., 41, 571–591. JAYASUNDAR, S. & VOHRA, M. M. (1978). An analysis of action of nicotinic agents on adrenergic nerve terminals in rat isolated vas deferens. Arch. Int. Pharmacodyn. Ther., 232, 192–201. JAYASUNDAR, S. & VOHRA, M. M. (1980). Recent studies of the actions of cholinomimetic drugs on adrenergic nerves and their implications for the cholinergic link hypothesis. Can J. Physiol. Pharmac., 58, 1–6. KUNTZMAN, R. & JACOBSON, M. M. (1963). Monoamine oxidase inhibition by a series of compounds structurally related to bretylium and guanethidine. J. Pharmac. exp. Ther., 141, 166–172. MAXWELL, R. A., MULL, R. P., & PLUMMER, A. J. (1959). (2-(octahydro-l-azocinyl)-ethyl)-guanidine sulfate (Ciba SU5864) a new synthetic antihypertensive agent. Experientia (Basel), 15, 267. MAXWELL, R. A., PLUMMER, A. J., SCHNEIDER, F., POVALSKI, H. & DANIEL, A. I. (1960). Pharmacology of (2-(octahydro-l-azocinyl)-ethyl)-guanidine sulphate (SU.5864). J. Pharmac. exp. Ther., 128, 22–29. MAXWELL, R. A. & WASTILA, W. B. (1977). Adrenergic neuron blocking drugs. In Handb. exp. Pharm. 39: Antihypertensive Agents. F. Gross Ed. pp. 161–261. Berlin , Heidelberg , New York : Springer-Verlag. MCCOUBREY, A. (1962). Biochemical properties of bretylium. J. Pharm. Pharmac., 14, 772–734. MITCHELL, J. R. & OATES, J. A. (1970). Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J. Pharmac. exp. Ther., 172, 100–107. MOE, R. A., BATES, H. M., PALKOSKI, Z. M. & BANZIGER, R. (1964). Cardiovascular effects of 3, 4-dihydro-2 (1H) isoquinoline carboxamidine (Declinax). Current Ther. Res., 6, 299–318. NASMYTH, P. A. & ANDREWS, W. H. H. (1959). The antagonism of cocaine by the action of choline 2, 6-xylyl ether bromide at sympathetic nerve endings. Br. J. Pharmac., 14, 477–483. PATON, W. D. M., ZAIMIS, E., BLACK, J. W. & GREEN, A. F. (1977). High blood pressure. The evolution of drug treatment: British contribution. In Highlights of British Science 223–240. Silver Jubilee Exhibition at the Royal Society, London , May 1977. PRICHARD, B. N. C., JOHNSTON, A. W., HILL, I. D. & ROSENHEIM, M. L. (1968). Bethanidine, guanethidine and methyldopa in treatment of hypertension: a within patient comparison. Br. med. J. 1, 135–144. PRICHARD, B. N. C. & WALDEN, R. J. (1979). Some major consequences of actions of drugs on the autonomic nervous system in man and experience of prediction from animal studies. Pharmac. Ther., 5, 55–59. SZEKERES, L. & PAPP, J. G. Y. (1980). Effect of adrenergic activators and inhibitors on the electrical activity of the heart. In Handb. exp. Pharm. 54/1: Adrenergic Activators and Inhibitors. L. Szekeres Ed. pp 597–650. Berlin , Heidelberg , New York : Springer-Verlag. TAYLOR, S. H. & DONALD, K. W. (1960). The circulatory effects of bretylium tosylate and guanethidine. Lancet, ii, 389–394. Citing Literature Volume1, Issue3June 1981Pages 255-267 ReferencesRelatedInformation" @default.
• W2028093661 created "2016-06-24" @default.
• W2028093661 creator A5012824827 @default.
• W2028093661 creator A5040854887 @default.
• W2028093661 date "1981-06-01" @default.
• W2028093661 modified "2023-09-25" @default.
• W2028093661 title "HISTORICAL PERSPECTIVE NORADRENERGIC NEURONE BLOCKING AGENTS" @default.
• W2028093661 cites W109873152 @default.
• W2028093661 cites W1965348568 @default.
• W2028093661 cites W1965640406 @default.
• W2028093661 cites W1967036712 @default.
• W2028093661 cites W1974259974 @default.
• W2028093661 cites W1984662835 @default.
• W2028093661 cites W1998117061 @default.
• W2028093661 cites W1999825679 @default.
• W2028093661 cites W2005232781 @default.
• W2028093661 cites W2014354061 @default.
• W2028093661 cites W2021274428 @default.
• W2028093661 cites W2038526879 @default.
• W2028093661 cites W2041766953 @default.
• W2028093661 cites W2042215051 @default.
• W2028093661 cites W2043160791 @default.
• W2028093661 cites W2044241017 @default.
• W2028093661 cites W2047023706 @default.
• W2028093661 cites W2051656854 @default.
• W2028093661 cites W2052397672 @default.
• W2028093661 cites W2067583385 @default.
• W2028093661 cites W2067753855 @default.
• W2028093661 cites W2078849957 @default.
• W2028093661 cites W2080615969 @default.
• W2028093661 cites W2135350647 @default.
• W2028093661 cites W2166900110 @default.
• W2028093661 cites W2171285254 @default.
• W2028093661 cites W2181205308 @default.
• W2028093661 cites W2291270621 @default.
• W2028093661 cites W2580613925 @default.
• W2028093661 cites W2759672555 @default.
• W2028093661 cites W36211478 @default.
• W2028093661 doi "https://doi.org/10.1111/j.1474-8673.1981.tb00454.x" @default.
• W2028093661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7040400" @default.
• W2028093661 hasPublicationYear "1981" @default.
• W2028093661 type Work @default.
• W2028093661 sameAs 2028093661 @default.
• W2028093661 citedByCount "6" @default.
• W2028093661 crossrefType "journal-article" @default.
• W2028093661 hasAuthorship W2028093661A5012824827 @default.
• W2028093661 hasAuthorship W2028093661A5040854887 @default.
• W2028093661 hasConcept C12713177 @default.
• W2028093661 hasConcept C144745244 @default.
• W2028093661 hasConcept C154945302 @default.
• W2028093661 hasConcept C15744967 @default.
• W2028093661 hasConcept C169760540 @default.
• W2028093661 hasConcept C31258907 @default.
• W2028093661 hasConcept C41008148 @default.
• W2028093661 hasConcept C71924100 @default.
• W2028093661 hasConcept C98274493 @default.
• W2028093661 hasConceptScore W2028093661C12713177 @default.
• W2028093661 hasConceptScore W2028093661C144745244 @default.
• W2028093661 hasConceptScore W2028093661C154945302 @default.
• W2028093661 hasConceptScore W2028093661C15744967 @default.
• W2028093661 hasConceptScore W2028093661C169760540 @default.
• W2028093661 hasConceptScore W2028093661C31258907 @default.
• W2028093661 hasConceptScore W2028093661C41008148 @default.
• W2028093661 hasConceptScore W2028093661C71924100 @default.
• W2028093661 hasConceptScore W2028093661C98274493 @default.
• W2028093661 hasIssue "3" @default.
• W2028093661 hasLocation W20280936611 @default.
• W2028093661 hasLocation W20280936612 @default.
• W2028093661 hasOpenAccess W2028093661 @default.
• W2028093661 hasPrimaryLocation W20280936611 @default.
• W2028093661 hasRelatedWork W1995515455 @default.
• W2028093661 hasRelatedWork W2082476859 @default.
• W2028093661 hasRelatedWork W2095322754 @default.
• W2028093661 hasRelatedWork W2098170879 @default.
• W2028093661 hasRelatedWork W2605852498 @default.
• W2028093661 hasRelatedWork W2748952813 @default.
• W2028093661 hasRelatedWork W2899084033 @default.
• W2028093661 hasRelatedWork W3031052312 @default.
• W2028093661 hasRelatedWork W3032375762 @default.
• W2028093661 hasRelatedWork W4250032403 @default.
• W2028093661 hasVolume "1" @default.
• W2028093661 isParatext "false" @default.
• W2028093661 isRetracted "false" @default.
• W2028093661 magId "2028093661" @default.
• W2028093661 workType "article" @default.